Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$ 31,806	$ 17,525
Prepaid expenses and other current assets	10,331	1,548
Total Current Assets	42,137	19,073
Property and equipment, net	483	65
Deposits and other assets	14	6
Total Assets	42,634	19,144
Current Liabilities:
Accounts payable	6,026	996
Accrued expenses	244	1,298
Warrant liabilities	10,662	6,756
Accrued employee benefits	314	538
Deferred rent	55	0
Total Current Liabilities	17,301	9,588
Long term deferred rent	198	0
Total Liabilities	17,499	9,588
Commitments and Contingencies	0	0
Stockholders’ Equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized, none issued and outstanding	0	0
Common stock, $0.001 par value; 250,000,000 shares authorized, 90,891,568 issued and 90,810,086 outstanding, and 100,000,000 shares authorized 72,594,626 issued and 72,513,144 outstanding	91	72
Additional paid-in capital	159,574	110,526
Accumulated deficit	(133,797)	(101,042)
Total Synthetic Biologics, Inc. and Subsidiaries Equity	25,868	9,556
Non-controlling interest	(733)	0
Total Stockholders' Equity	25,135	9,556
Total Liabilities and Stockholders' Equity	$ 42,634	$ 19,144